APA (7th ed.) Citation

LS, K., SS, K., IB, C., & AV, B. (2016). Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition. The journal of gene medicine, 18(9), 220. https://doi.org/10.1002/jgm.2894

Chicago Style (17th ed.) Citation

LS, Krassikova, Karshieva SS, Cheglakov IB, and Belyavsky AV. "Combined Treatment, Based on Lysomustine Administration with Mesenchymal Stem Cells Expressing Cytosine Deaminase Therapy, Leads to Pronounced Murine Lewis Lung Carcinoma Growth Inhibition." The Journal of Gene Medicine 18, no. 9 (2016): 220. https://doi.org/10.1002/jgm.2894.

MLA (9th ed.) Citation

LS, Krassikova, et al. "Combined Treatment, Based on Lysomustine Administration with Mesenchymal Stem Cells Expressing Cytosine Deaminase Therapy, Leads to Pronounced Murine Lewis Lung Carcinoma Growth Inhibition." The Journal of Gene Medicine, vol. 18, no. 9, 2016, p. 220, https://doi.org/10.1002/jgm.2894.